Economic benefits of adult upper limb spasticity treatment with abobotulinumtoxinA compared with onabotulinumtoxinA or incobotulinumtoxinA: Analysis of a real-life setting in France

Authors :: Laurence de Oliveira
Diana Velickovic
Laure Rousset
Alexis Schnitzler
Natalya Danchenko
Source :: Toxicon. 156:S103-S104
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: medicine.medical_specialty
Physical medicine and rehabilitation
business.industry
Medicine
Upper limb spasticity
Toxicology
business
Real life setting
Economic benefits

Full Text Access

Tools